Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches
Open accessThe DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.
Abstract
Invasive, life-threatening fungal infections are an important cause of morbidity and mortality, particularly for patients with compromised immune function. The number of therapeutic options for the treatment of invasive fungal infections is quite limited when compared with those available to treat bacterial infections. Indeed, only three classes of molecules are currently used in clinical practice and only one new class of antifungal drugs has been developed in the last 30 years. Here we summarize the unmet clinical needs of current antifungal therapy, discuss challenges inherent to antifungal drug discovery and development, and review recent developments aimed at addressing some of these challenges.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Organelles such as the vacuole make important contributions to tolerance and/or trailing growth.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [94]
In the citing paper
“In Saccharomyces cerevisiae several genes involved in retrograde trafficking modulate tolerance and/or trailing growth, including VPS2127,51, VPS15 and VPS5194; Rim101 may influence tolerance via its ability to regulate the transcription of key components of the vacuolar trafficking pathway95.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [94]
In the citing paper
“Despite extensive efforts, target-based cell-free screening of synthetic chemical libraries has failed to deliver any new classes of antifungals or antibacterials in clinical practice (Payne et al., 2007; Roemer and Krysan, 2014).”
From A Fungal-Selective Cytochrome bc1 Inhibitor Impairs Virulence and Prevents the Evolution of Drug Resistance (2016) · cites this paper as Roemer and Krysan, 2014
Citations
Cites
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Functional profiling of the Saccharomyces cerevisiae genome
Giaever, G., Chu, A. M., Ni, L., Connelly, C., Riles, L., Véronneau, S., Dow, S., Lucau-Danila, A., Anderson, K., André, B., et al. (2002) · Nature · doi:10.1038/nature00935 · Cited by 4,316
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
The Genetic Landscape of a Cell
Costanzo, M., Baryshnikova, A., Bellay, J., Kim, Y., Spear, E. D., Sevier, C. S., Ding, H., Koh, J. L. Y., Toufighi, K., Mostafavi, S., et al. (2010) · Science · doi:10.1126/science.1180823 · Cited by 2,162
Park, B. J., Wannemuehler, K. A., Marston, B. J., Govender, N., Pappas, P. G., & Chiller, T. M. (2009) · AIDS · doi:10.1097/qad.0b013e328322ffac · Cited by 2,014
Platforms for antibiotic discovery
Lewis, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3975 · Cited by 1,445
Pierce, C. G., Uppuluri, P., Tristan, A. R., Wormley, F. L., Mowat, E., Ramage, G., & Lopez-Ribot, J. L. (2008) · Nature Protocols · doi:10.1038/nprot.2008.141 · Cited by 1,041
Amphotericin B formulations: a comparative review of efficacy and toxicity
Hamill, R. J. (2013) · Drugs · doi:10.1007/s40265-013-0069-4 · Cited by 807
Cited by
Items 201–300 of 620
Carrizo, S. L., Zampini, I. C., Sayago, J. E., Simirgiotis, M. J., Bórquez, J., Cuello, A. S., & Isla, M. I. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112553 · Cited by 26
Candida antifungal drug resistance in sub-Saharan African populations: A systematic review
Africa, C. W. J., & Abrantes, P. M. D. S. (2016) · F1000Research · doi:10.12688/f1000research.10327.1 · Cited by 29
Hartland, K., Pu, J., Palmer, M., Dandapani, S., Moquist, P. N., Munoz, B., DiDone, L., Schreiber, S. L., & Krysan, D. J. (2016) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00111 · Cited by 24
Self-citationThe Significance of Mono‐ and Dual‐Effective Agents in the Development of New Antifungal Strategies
Zobi, C., & Algül, Ö. (2025) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70045 · Cited by 26
Recent Advances in the Development of Antifungal Agents: Beyond Azoles, Polyenes, and Echinocandins
Saini, V., Safwan, S. M., Mehta, D., Das, E. E., & Bajaj, A. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00828 · Cited by 25
Discovery of simplified sampangine derivatives as novel fungal biofilm inhibitors
Liu, N., Zhong, H., Tu, J., Jiang, Z., Jiang, Y., Jiang, Y., Jiang, Y., Li, J., Zhang, W., Wang, Y., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.10.043 · Cited by 25
DectiSomes: C-type lectin receptor-targeted liposomes as pan-antifungal drugs
Meagher, R. B., Lewis, Z., Ambati, S., & Lin, X. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114776 · Cited by 27
Fighting pathogenic yeasts with plant defensins and anti-fungal proteins from fungi
Manzanares, P., Giner‐Llorca, M., Marcos, J. F., & Garrigues, S. (2024) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-024-13118-1 · Cited by 24
Isolation of conditional mutations in genes essential for viability of Cryptococcus neoformans
Ianiri, G., Boyce, K. J., & Idnurm, A. (2016) · Current Genetics · doi:10.1007/s00294-016-0659-2 · Cited by 25
Xu, C., Nikolova, O. H., Basom, R., Mitchell, R. M., Shaw, R. C., Moser, R. D., Park, H., Gurley, K. E., Kao, M. C., Green, C. L., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1339 · Cited by 26
Host defence peptides identified in human apolipoprotein B as promising antifungal agents
Dell’Olmo, E., Gaglione, R., Cesaro, A., Cafaro, V., Teertstra, W. R., de Cock, H., Notomista, E., Haagsman, H. P., Veldhuizen, E. J. A., & Arciello, A. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11114-3 · Cited by 24
Campione, E., Gaziano, R., Doldo, E., Marino, D., Falconi, M., Iacovelli, F., Tagliaferri, D., Pacello, L., Bianchi, L., Lanna, C., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01874-20 · Cited by 23
Molecular basis of the inositol deacylase PGAP1 involved in quality control of GPI-AP biogenesis
Hong, J., Li, T., Chao, Y., Xu, Y., Zhu, Z., Zhou, Z., Gu, W., Qu, Q., & Li, D. (2024) · Nature Communications · doi:10.1038/s41467-023-44568-2 · Cited by 25
Silver Nanoparticles: A Novel Antimicrobial Agent
Yun, J., & Lee, D. G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-52733-0.00006-9 · Cited by 23
Climate change and antimicrobial resistance
Kalanxhi, E., & Laxminarayan, R. (2026) · Nature Reviews Microbiology · doi:10.1038/s41579-026-01285-z · Cited by 32
Anticapsular and Antifungal Activity of α-Cyperone
Horn, C., & Vediyappan, G. (2021) · Antibiotics · doi:10.3390/antibiotics10010051 · Cited by 25
Pharmaceutical Multicomponent Crystals of Antifungal Drugs with Improved Dissolution Performance
Drozd, K. V., Manin, A. N., Boycov, D. E., Churakov, A. V., & Perlovich, G. L. (2021) · Crystal Growth & Design · doi:10.1021/acs.cgd.1c01139 · Cited by 22
Kashyap, V. H., Mishra, A., Bordoloi, S., Varma, A. K., & Joshi, N. C. (2023) · Mycoses · doi:10.1111/myc.13619 · Cited by 24
Nanotechnology-based fungal detection and treatment: current status and future perspective
Chaudhari, V., Vairagade, V., Thakkar, A., Shende, H., & Vora, A. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02662-8 · Cited by 25
Biomimetic Antifungal Materials: Countering the Challenge of Multidrug-Resistant Fungi
Khalifa, H. O., Oreiby, A. F., Abdelhamid, M. A. A., Ki, M., & Pack, S. P. (2024) · Biomimetics · doi:10.3390/biomimetics9070425 · Cited by 23
Alfatah, M., Bari, V. K., Nahar, A. S., Bijlani, S., & Ganesan, K. (2017) · Scientific Reports · doi:10.1038/srep40281 · Cited by 24
Repurposing Nonantifungal Approved Drugs for Synergistic Targeting of Fungal Pathogens
Vallières, C., Singh, N., Alexander, C., & Avery, S. V. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00405 · Cited by 27
Candida antifungal drug resistance in sub-Saharan African populations: A systematic review
Africa, C. W. J., & Abrantes, P. M. D. S. (2017) · F1000Research · doi:10.12688/f1000research.10327.2 · Cited by 30
Editorial: Antifungal Drug Discovery: New Theories and New Therapies
Seneviratne, C. J., & Rosa, E. A. R. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00728 · Cited by 25
In Vitro and In Vivo Study of Amphotericin B Formulation with Quaternized Bioreducible Lipidoids
Liu, F., Yang, L., Li, Y., Junier, A., Ma, F., Chen, J., Han, H., Glass, Z., Zhao, X., Kumamoto, C. A., et al. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01722 · Cited by 21
Janowska, S., Khyluk, D., Janowski, M., Kosikowska, U., Strzyga‐Łach, P., Struga, M., & Wujec, M. (2023) · Molecules · doi:10.3390/molecules28062718 · Cited by 22
Small molecules restore azole activity against drug-tolerant and drug-resistant Candida isolates
Alabi, P., Gautier, C., Murphy, T. P., Gu, X., Lepas, M., Aimanianda, V., Sello, J. K., & Ene, I. V. (2023) · mBio · doi:10.1128/mbio.00479-23 · Cited by 30
Recent Advances in Understanding the Human Fungal Pathogen Hypoxia Response in Disease Progression
Puerner, C. T. S., Vellanki, S., Strauch, J. L., & Cramer, R. A. (2023) · Annual Review of Microbiology · doi:10.1146/annurev-micro-032521-021745 · Cited by 23
Mishra, S., Kaur, M., Chander, S., Murugesan, S., Nim, L., Arora, D. S., & Singh, P. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.06.039 · Cited by 23
Li, Y., Dai, M., Zhang, Y., & Lü, L. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11104-5 · Cited by 24
All-Trans Retinoic Acid Effect on Candida albicans Growth and Biofilm Formation
Pistoia, E. S., Cosio, T., Campione, E., Pica, F., Volpe, A., Marino, D., Francesco, P. D., Monari, C., Fontana, C., Favaro, M., et al. (2022) · Journal of Fungi · doi:10.3390/jof8101049 · Cited by 21
The Gpi Anchor Pathway: A Promising Antifungal Target?
Mutz, M. W., & Roemer, T. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0110 · Cited by 21
Self-citationIdentification and Elimination of Antifungal Tolerance in Candida auris
Rasouli Koohi, S., Shankarnarayan, S. A., Galon, C. M., & Charlebois, D. A. (2023) · Biomedicines · doi:10.3390/biomedicines11030898 · Cited by 20
Repositioning Antimicrobial Peptides Against WHO‐Priority Fungi
Roque‐Borda, C. A., Medina‐Alarcón, K. P., Pereira, J. P. S. G., Sevilhano, T. C. D. A., Aguilar‐Morón, B., Díaz‐Cárdenas, F., da Cruz, L. S., Júnior, F. H. X., Vicente, E. F., Perdigão, J., et al. (2025) · Advanced Science · doi:10.1002/advs.202509567 · Cited by 24
Lu, R.-Y., Ni, T., Wu, J., Yan, L., Lv, Q., Li, L., Zhang, D., & Jiang, Y. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01628-19 · Cited by 22
Pavić, A., Savić, N. D., Glišić, B. Đ., Crochet, A., Vojnović, S., Kurutos, A., Stanković, D. M., Fromm, K. M., Nikodinović‐Runić, J., & Djuran, M. I. (2019) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2019.03.017 · Cited by 20
Deaguero, I. G., Huda, M. N., Rodriguez, V., Zicari, J. E., Al-Hilal, T. A., Badruddoza, A. Z. M., & Nurunnabi, M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12060516 · Cited by 25
Zoidis, G., Kritsi, E., Lecinska, P., Ivanov, M., Zoumpoulakis, P. G., Sokóvić, M., & Catto, M. (2020) · ChemMedChem · doi:10.1002/cmdc.202000312 · Cited by 24
Haroun, M., Tratrat, C., Petrou, A., Geronikaki, A. A., Ivanov, M., Ćirić, A., Sokóvić, M., Sreeharsha, N., Venugopala, K. N., Nair, A. B., et al. (2021) · Molecules · doi:10.3390/molecules26134061 · Cited by 20
Ortiz, S. C., Huang, M., & Hull, C. M. (2021) · mBio · doi:10.1128/mbio.01672-21 · Cited by 20
Li, X., Xu, Y., Ouyang, D., Ye, K., Chen, Y., Li, Q., Xia, Q., Wu, X., & Yang, Y. (2022) · Biochemical Engineering Journal · doi:10.1016/j.bej.2022.108791 · Cited by 21
Jothi, R., Sangavi, R., Veerapandian, R., Kumar, P., Pandian, S. K., & Gowrishankar, S. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20010027 · Cited by 22
Sargsyan, T. H., Stepanyan, L., Panosyan, H. А., Hakobyan, H., Israyelyan, M. H., Tsaturyan, A., Hovhannisyan, N., Vicidomini, C., Mkrtchyan, A. F., Saghyan, A. S., et al. (2025) · Biomolecules · doi:10.3390/biom15010061 · Cited by 23
Promising antifungal activity of new oxadiazole against Candida krusei
Faria, D. R., Sakita, K. M., Capoci, I. R. G., Arita, G. S., Rodrigues-Vendramini, F. A. V., de Oliveira, A. G., Felipe, M. S. S., Mendonca, P., Svidzinski, T. I. E., & Kioshima, É. S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227876 · Cited by 20
Khalaf, R. A., Fattouh, N., Medvecký, M., & Hrabák, J. (2021) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001351 · Cited by 21
Malinowska, M., Sawicka, D., Niemirowicz-Laskowska, K., Wielgat, P., Car, H., Hauschild, T., & Hryniewicka, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212180 · Cited by 18
Azole Combinations and Multi-Targeting Drugs That Synergistically Inhibit Candidozyma auris
Toepfer, S., Keniya, M. V., Lackner, M., & Monk, B. C. (2024) · Journal of Fungi · doi:10.3390/jof10100698 · Cited by 23
Tits, J., Berman, J. G., Cammue, B. P. A., & Thevissen, K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.617214 · Cited by 21
Biofilm: A Robust and Efficient Barrier to Antifungal Chemotherapy
Souza dos Santos, A. L., & de Mello, T. P. (2015) · Journal of Antimicrobial Agents · doi:10.4172/2472-1212.1000e101 · Cited by 19
Micro- and Nanoscale Approaches in Antifungal Drug Discovery
Willaert, R. (2018) · Fermentation · doi:10.3390/fermentation4020043 · Cited by 18
Arockianathan, P. M., Mishra, M., & Niranjan, R. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190412102037 · Cited by 19
Gerlach, E. S., Altamirano, S., Yoder, J. M., Luggya, T. S., Akampurira, A., Meya, D. B., Boulware, D. R., Rhein, J., & Nielsen, K. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.695240 · Cited by 17
Review of Recent Medicinal Applications of Rhenium(I) Tricarbonyl Complexes
Towett, E. K., Kemboi, D., Tembu, V. J., Langat, M. K., & Manicum, A.-L. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26147005 · Cited by 17
Pries, V., Cotesta, S., Riedl, R., Aust, T., Schuierer, S., Tao, J., Filipuzzi, I., & Hoepfner, D. (2015) · SLAS DISCOVERY · doi:10.1177/1087057115610488 · Cited by 18
A New Small-Molecule KRE2 Inhibitor Against Invasive Candida Parapsilosis Infection
Salci, T. P., Negri, M., Abadio, A. K. R., Mendonca, P., Capoci, I. R. G., Caparroz‐Assef, S. M., Donatti, L., Felipe, M. S. S., Kioshima, É. S., & Svidzinski, T. I. E. (2017) · Future Microbiology · doi:10.2217/fmb-2017-0065 · Cited by 17
Mayer, F. L., Sánchez‐León, E., & Kronstad, J. W. (2018) · Microbial Cell · doi:10.15698/mic2018.11.656 · Cited by 19
Rollin‐Pinheiro, R., Bayona-Pacheco, B. L., Domingos, L. T. S., Curvelo, J. A. D. R., de Castro, G. M. M., Barreto‐Bergter, E., & Ferreira‐Pereira, A. (2021) · Pathogens · doi:10.3390/pathogens10070856 · Cited by 18
Newer Patents in Antimycotic Therapy
Shahid, S. K. (2016) · Pharmaceutical Patent Analyst · doi:10.4155/ppa-2015-0001 · Cited by 18
The Repurposing of Anti-Psychotic Drugs, Quetiapine and Olanzapine, as Anti-Cryptococcus Drugs
Ogundeji, A. O., Pohl, C. H., & Sebolai, O. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00815 · Cited by 17
Smiljkovic, M. S., Kostić, M., Stojković, D. S., Glamočlija, J., & Sokóvić, M. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180629133218 · Cited by 17
Wani, M. Y., Ahmad, A., Aqlan, F. M., & Al‐Bogami, A. S. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00030 · Cited by 18
Bacillus Metabolites: Compounds, Identification and Anti-Candida albicans Mechanisms
Wang, W., Zhao, J., & Zhang, Z. (2022) · Microbiology Research · doi:10.3390/microbiolres13040070 · Cited by 20
Ristovski, J. T., Janković, N., Borčić, V., Jain, S., Bugarčić, Z., & Mikov, M. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2018.03.038 · Cited by 16
Antifungal Biofilm Inhibitory Effects of Combinations of Diclofenac and Essential Oils
Barbarossa, A., Rosato, A., Carrieri, A., Tardugno, R., Corbo, F., Clodoveo, M. L., Fracchiolla, G., & Carocci, A. (2023) · Antibiotics · doi:10.3390/antibiotics12121673 · Cited by 15
Nanoformulations for dismantling fungal biofilms: The latest arsenals of antifungal therapy
Gupta, P., Meher, M. K., Tripathi, S., & Poluri, K. M. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101290 · Cited by 18
Genomic Approaches to Antifungal Drug Target Identification and Validation
Robbins, N., & Cowen, L. E. (2022) · Annual Review of Microbiology · doi:10.1146/annurev-micro-041020-094524 · Cited by 16
Emerging Polymer-Based Nanosystem Strategies in the Delivery of Antifungal Drugs
Xin, Y., Liang, Q., Zhang, H., & Ao, Q. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071866 · Cited by 18
Kumar, Y., Wani, F. A., Ahmedi, S., Shamsi, A., Nadeem, M., Manzoor, N., Kamli, M. R., Malik, M. A., Rizvi, M. M. A., & Patel, R. (2024) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2024.124631 · Cited by 16
Inhibition of Vesicular Transport Influences Fungal Susceptibility to Fluconazole
Demuyser, L., Dyck, K. V., Timmermans, B., & Dijck, P. V. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01998-18 · Cited by 15
Lafita‐Navarro, M. C., Liaño-Pons, J., Quintanilla, A., Varela, I., Blanco, R. E., Ourique, F., Bretones, G., Aresti, J., Molina, E., Carroll, P. A., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010389 · Cited by 15
The antifungal pipeline: the need is established. Are there new compounds?
Li, D., She, X., & Calderone, R. (2020) · FEMS Yeast Research · doi:10.1093/femsyr/foaa023 · Cited by 16
Innovative therapies for invasive fungal infections in preclinical and clinical development
Yu, Y., Albrecht, K., Gröll, J., & Beilhack, A. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1791819 · Cited by 19
Aşkun, T. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100869 · Cited by 16
Glucose Metabolism and Use of Alternative Carbon Sources in Medically-Important Fungi
Chew, S. Y., & Than, L. T. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819990-9.00068-8 · Cited by 19
Luna-Tapia, A., Butts, A., & Palmer, G. E. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01337-18 · Cited by 14
Research advances and public health strategies in China on WHO priority fungal pathogens
Wang, Y., Han, L., Gong, J., Liu, L., Miao, B., & Xu, J. (2025) · Mycology: An International Journal on Fungal Biology · doi:10.1080/21501203.2025.2561612 · Cited by 15
Zhao, L., Sun, Y., Yin, W., Tian, L., Sun, N., Zheng, Y., Zhang, C., Zhao, S., Su, X., Zhao, D., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113987 · Cited by 14
Li, Y., Dai, M., Lü, L., & Zhang, Y. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00325-23 · Cited by 16
Thakur, R., Shishodia, S. K., Sharma, A., Chauhan, A., Kaur, S., & Shankar, J. (2024) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2024.100220 · Cited by 16
Gutierrez-Perez, C., Puerner, C. T. S., Jones, J. T., Vellanki, S., Vesely, E. M., Xatse, M. A., Viera, A. F. C., Olsen, C. P., Attiku, K. O., Cardinale, S. C., et al. (2024) · mBio · doi:10.1128/mbio.01166-24 · Cited by 17
Yang, G., Shi, W., He, W., Wu, J., Huang, S., Li, M., Zhang, J., Wang, H., & Zhou, X. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.01172-24 · Cited by 14
Ambati, S., Li, Y., Whittaker, M. K., Kennedy, E. J., Najahi‐Missaoui, W., Lin, X., Lewis, Z., & Meagher, R. B. (2025) · Communications Materials · doi:10.1038/s43246-025-00749-8 · Cited by 14
Asim, M. N., Asif, T., Mehmood, F., & Dengel, A. R. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.109821 · Cited by 15
Antifungal Properties of Nerolidol-Containing Liposomes in Association with Fluconazole
Bezerra, C. F., Júnior, J. G. D. A. S., Honorato, R. D. L., dos Santos, A. T. L., da Silva, J. C. P., da Silva, T. G., Leal, A. L. A. B., de Freitas, T. S., Vieira, T. A. T., Rocha, J. E., et al. (2020) · Membranes · doi:10.3390/membranes10090194 · Cited by 16
Chakraborti, S., Ramakrishnan, G., & Srinivasan, N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00016-x · Cited by 16
Ceballos-Garzón, A., Román, E., Plá, J., Pagniez, F., Amado, D., Alméciga-Díaz, C. J., Pape, P. L., & Parra‐Giraldo, C. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265777 · Cited by 14
Zhai, P., Chai, Y., & Lü, L. (2022) · Microorganisms · doi:10.3390/microorganisms10122469 · Cited by 13
Biogenesis, germination, and pathogenesis of Cryptococcus spores
Ortiz, S. C., & Hull, C. M. (2024) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00196-23 · Cited by 15
Ismail, S. A., Fayed, B. E., Abdelhameed, R. M., & Hassan, A. A. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03414-1 · Cited by 13
Duus, R. M., Moeller, J. B., & Rathe, M. (2024) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piae079 · Cited by 13
Fungal Infections, Treatment and Antifungal Resistance: The Sub-Saharan African Context
Boakye-Yiadom, E., Odoom, A., Osman, A.-H., Ntim, O. K., Kotey, F. C. N., Ocansey, B. K., & Donkor, E. S. (2024) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361241297525 · Cited by 17
Andrés, M. V., Català, C., Carrillo‐Serradell, L., Planells-Romeo, V., Aragón-Serrano, L., Español‐Rego, M., Pérez-Amill, L., Puerta‐Alcalde, P., García‐Vidal, C., Juan, M., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.09.003 · Cited by 14
Duca, M., Haksar, D., van Neer, J., Thies‐Weesie, D. M. E., Martínez-Alarcón, D., de Cock, H., Varrot, A., & Pieters, R. J. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00708 · Cited by 14
Jamzivar, F., Shams‐Ghahfarokhi, M., Khoramizadeh, M., Yousefi, N., Gholami‐Shabani, M., & Razzaghi‐Abyaneh, M. (2020) · Iranian Journal of Microbiology · doi:10.18502/ijm.v11i6.2216 · Cited by 17
Genotypic and Phenotypic Changes in Candida albicans as a Result of Cold Plasma Treatment
Tyczkowska-Sieroń, E., Kałużewski, T., Grabiec, M., Kałużewski, B., & Tyczkowski, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218100 · Cited by 14
Vanherp, L., Poelmans, J., Hillen, A., Janbon, G., Brock, M., Lagrou, K., Velde, G. V., & Himmelreich, U. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00070-20 · Cited by 14
El-Sayed, S. E., El-Housseiny, G. S., Abdelaziz, N. A., El‐Ansary, M. R., & Aboshanab, K. M. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s267590 · Cited by 13
Jain, M., Reddy, C., Halder, M., Singh, S., Kumar, R., Wasudeo, S. G., Singh, P. P., Khan, S. I., Jacob, M. R., Tekwani, B. L., et al. (2018) · ACS Omega · doi:10.1021/acsomega.7b02047 · Cited by 13
Goughenour, K. D., Creech, A., Xu, J., He, X., Hissong, R., Giamberardino, C. D., Tenor, J. L., Toffaletti, D. L., Perfect, J. R., & Olszewski, M. A. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1392015 · Cited by 12
Redrado, S., Macías‐León, J., Castro-López, J., Sanz, A. B., Dolader, E., Arias, M. A., González‐Ramírez, A. M., Sánchez‐Navarro, D., Petryk, Y., Farkaš, V., et al. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202405823 · Cited by 15
Metadata
- Authors
- Roemer, T., & Krysan, D. J.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- University of Rochester Medicine (US)
- ORCID
- Krysan, D. J.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2014-05-01
- Volume
- 4
- Issue
- 5
- Pages
- a019703-a019703
- ISSN
- 2157-1422 (ISSN-L)
- PMC
- PMC3996373
- OpenAlex
- W2134122507
- Cited by
- 593
- References
- 78
- Citations by year
- 2026: 39 · 2025: 56 · 2024: 69 · 2023: 51 · 2022: 58 · 2021: 68 · 2020: 71 · 2019: 42 · 2018: 50 · 2017: 38 · 2016: 30 · 2015: 18 · 2014: 3
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Rochester
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI097142, R01AI091422)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- antifungal drug development, invasive fungal infections, antifungal drug discovery, unmet clinical needs, immunocompromised patients
- MeSH terms
- Antifungal Agents, Forecasting, Humans, Mycoses, Technology, Pharmaceutical, Treatment Outcome, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.